10:15 AM EST - Greenbrook TMS Inc. : And Neuronetics, Inc, a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in the world, today announced they have entered into a five-year commercial agreement which provides for a stronger collaborative relationship between the parties. Greenbrook TMS Inc.
shares T.GTMS are trading down $0.03 at $3.44.
